About LyfeSci Research & Innovation
Empowering Drug Development for Innovators
At LyfeSci Research & Innovation, we believe life sciences innovation is attainable for all—from biotech and drug startups to large pharmaceutical companies. Our mission is to empower every player in the pharmaceutical and biotechnology sectors, guiding them through the complexities of drug development, from discovery to clinical trials, with a tailored, customer-centric approach.
Delivering Scalable Solutions
We provide strategic consulting in pre-IND phases, helping clients secure the necessary resources up to the IND application, and offer comprehensive solutions for in-human studies to ensure regulatory compliance, quality, and efficiency. For smaller companies, we offer agile, personalized processes, while our scalable capacity meets the demands of larger organizations. Our global partnerships—from Europe to Asia—with cutting-edge innovators enable us to deliver full-service options that support the discovery of treatments with the potential to improve lives.
Driving Meaningful Change
At LyfeSci, our commitment lies in innovation, integrity, and impactful collaboration. We aim to ambitiously and radically reshape the life sciences landscape by delivering clinical trial solutions and strategic consulting that exceed client expectations. Our vision is to accelerate the development of life-saving treatments, ensuring that innovation in life sciences remains accessible and impactful for companies of all sizes. We strive to lead the field by fostering excellence and supporting clients as they navigate complex regulatory pathways and scientific challenges.
Our Leadership Team
Meet the visionary leaders driving innovation in clinical research and pharmaceutical development
Tapan Parikh, MD, MPH
Founder & President/CEO
Dr. Tapan Parikh is a dual board-certified psychiatrist in adult and child/adolescent psychiatry with over 15 years of dynamic clinical and research experience spanning cardiology, oncology, neurosciences, and public health. He is deeply passionate about solving inefficiencies in drug development and brings deep expertise as a recognized leader in the clinical trial world.
William E. Gannon Jr., MD, MBA
Chief Medical Officer
Dr. Gannon brings over 35 years of experience in the management of clinical trials, including trial design and building operational teams to ensure successful completion. He is an expert in regulatory strategies, regulatory submissions, and the execution of Phase I through Phase IV clinical trials.
Ritvij Satodiya, MD
Medical Director
Dr. Ritvij Satodiya is a board-certified psychiatrist with a strong focus on clinical research, psychopharmacology, and CNS drug development. He brings over a decade of combined experience in clinical psychiatry and a wide range of industry-sponsored CNS clinical trials.
Myra Zerr-Korolev
Director, Operations
With over ten years of experience in the pharmaceutical and biotech industries, Myra specializes in clinical trial management, patient engagement and recruitment, and scientific communication. As a strategic leader, she has successfully developed and executed global clinical research strategies.